Reaction
Bladder Hypertrophy reporting signals
As of the last recalculation, Bladder Hypertrophy appears in 433 FAERS reports alongside 9 co-occurring drug terms. The strongest observed disproportionality signal is GANCICLOVIR (PRR 67.9).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Ganciclovir | 14 | 67.9 | 68.0 |
| Ganciclovir Sodium | 14 | 65.7 | 65.8 |
| Basiliximab | 14 | 59.1 | 59.2 |
| Busulfan | 12 | 37.7 | 37.7 |
| Fludarabine Phosphate | 28 | 36.5 | 36.6 |
| Amphetamine | 6 | 35.3 | 35.4 |
| Obinutuzumab | 11 | 33.0 | 33.0 |
| Polatuzumab Vedotin | 5 | 24.9 | 24.9 |
| Lacosamide | 14 | 18.7 | 18.7 |